Innovating Works

H2020

Cerrada
HORIZON-HLTH-2022-IND-13-02
Scaling up multi-party computation, data anonymisation techniques, and synthetic data generation
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 6 “Maintaining an innovative, sustainable and globally competitive health industry”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 1 al 20 de 230 resultados
LightCure: LightCure - Light for double specificity and efficacy without burden STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Congenital hyperinsulinism (CHI) is a group of rare diseases of newborns and infants with functionally defective nonneoplastic beta-cells th...
2024-01-01 - 2029-12-31 | Financiado
AI4LUNGS: AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION INESC TEC INSTITUTO DE ENGENHARIADE SISTEMAS E COMPUTADORES TECNOLOGIA E CIENCIA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage AI4Lungs will develop and validate novel AI-based tools and computational models to improve patient stratification optimising diagnosis and...
2023-12-07 - 2027-06-30 | Financiado
PoCCardio: Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk... MEDIZINISCHE UNIVERSITAT GRAZ tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Besides established risk factors such as elevated blood pressure, b...
2023-12-01 - 2028-11-30 | Financiado
CAPTIVATE: CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Malaria remains a serious health concern worldwide, with P. falciparum considered one of the deadliest human parasites. Yet, the currently a...
2023-11-01 - 2028-04-30 | Financiado
OBCT: Obesity: Biological, socioCultural, and environmental risk Trajectories STICHTING AMSTERDAM UMC tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Obesity in Europe disproportionately affects people and communities with a lower socioeconomic position (SEP). Effective preventive approach...
2023-11-01 - 2028-10-31 | Financiado
LEOPARD: Liver Electronic Offering Platform with Artificial intelligence-based Devices ASSISTANCE PUBLIQUE HOPITAUX DE PARIS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Liver transplantation (LT) is a life-saving procedure for decompensated cirrhosis (DC) and hepato-cellular carcinoma (HCC). Its efficacy is...
2023-11-01 - 2028-10-31 | Financiado
ARISTOTELES: Applying ARtificial Intelligence to Define clinical trajectorieS for personalized predicTiOn and ear... UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage The ARISTOTELES project aims to build a multinational harmonized data platform to develop and implement novel artificial intelligence (AI) a...
2023-11-01 - 2028-10-31 | Financiado
INSAFEDARE: INNOVATIVE APPLICATIONS OF ASSESSMENT AND ASSURANCE OF DATA AND SYNTHETIC DATA FOR REGULATORY DECISI... COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 INSAFEDARE aims to provide a toolkit to enable cost-effective and high assurance decision-making in the context of the processes that all st...
2023-11-01 - 2026-10-31 | Financiado
BETTER4U: Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you BETTER4U CHAROKOPEIO PANEPISTIMIO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage BETTER4U aims at the identification and personalized management of all weight gain determinants to battle the increasingly rising numbers of...
2023-10-23 - 2027-10-31 | Financiado
CYMEDSEC: Enhanced cybersecurity for networked medical devices through optimisation of guidelines, standards,... TECHNISCHE UNIVERSITAET DRESDEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-IND-13-01 For the EU health industry to be competitive and to sustainably deliver internationally leading care quality, it is important that EU regula...
2023-10-10 - 2027-10-31 | Financiado
PHEMS: Pediatric Hospitals as European drivers for multi-party computation and synthetic data generation ca... HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-IND-13-02 Cross-border collaboration can tackle the challenges in accessing relevant health data essential for international collaboration between sci...
2023-10-09 - 2026-09-30 | Financiado
DREAMS: Drug REpurposing with Artificial intelligence for Muscular disorderS CENTRE DETUDE DES CELLULES SOUCHES tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-04-two-stage According to World Health Organization, to date, fewer than 6% of rare diseases (RDs) have an approved treatment option. In the light of thi...
2023-10-08 - 2028-10-31 | Financiado
BIOTOOL-CHF: BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart fai... IRCCS AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Heart failure (HF) is a chronic clinical condition involving up to 6.5 million people in Europe, the most frequent cause of hospitalization...
2023-10-01 - 2028-09-30 | Financiado
ASP-belong: Augmented Social Play (ASP): smartphone-enabled group psychotherapeutic interventions that boost ado... Masarykova univerzita tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage "In our fast-changing society, poor mental health and social isolation are increasing among young people, exacerbated by the pandemic. Belon...
2023-09-01 - 2027-08-31 | Financiado
WORMVACS2.0: Innovations for vaccines against helminth infections ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Infections with parasitic worms (helminths) continue to cause a massive global health burden. Yet, effective vaccines to enable control and...
2023-09-01 - 2028-08-31 | Financiado
ADVANCE: ADDRESSING MENTAL HEALTH VULNERABILITIES FROM ADOLESCENCE TO OLDER AGE: INNOVATING PREVENTION SCIENC... KOBENHAVNS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Mental health has been identified as an urgent priority in Europe, but is under critical threat because of climate change, digitalization, s...
2023-07-01 - 2028-06-30 | Financiado
METASTRA: COMPUTER-AIDED EFFECTIVE FRACTURE RISK STRATIFICATION OF PATIENTS WITH VERTEBRAL METASTASES FOR PERS... ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Cancer patients (2.7M in Europe) with a positive prognosis are exposed to a high incidence of secondary tumours (≈1M). Bone metastases sprea...
2023-07-01 - 2028-06-30 | Financiado
BAXERNA 2.0: Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines VIB VZW tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage BAXERNA 2.0 will establish a new vaccine development pipeline based on dramatically improved immunopeptidomics screening and innovative mRNA...
2023-07-01 - 2028-06-30 | Financiado
Vax2Muc: NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MO... TECHNISCHE UNIVERSITAET MUENCHEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage To overcome antimicrobial resistance (AMR) compromising global public health, novel strategies to develop next generation vaccines against A...
2023-07-01 - 2028-06-30 | Financiado
AI-PROGNOSIS: Artificial intelligence-based Parkinson’s disease risk assessment and prognosis ARISTOTELIO PANEPISTIMIO THESSALONIKIS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, with a multifactorial aetiology, heterogeneous manifestatio...
2023-07-01 - 2027-06-30 | Financiado